<!doctype html>
<html lang="en">
<head>

<title>Screen</title>
<meta http-equiv="Content-Type" content="text/html;charset=utf-8">
    <link rel="stylesheet" type="text/css" href="css/page8.css" />
	<script>
	$(document).ready(function(){
        $('#audio-slideshow').udSynch();
	     
		    $(".nextFrame").text("Click/Tap forward arrow to continue");
            $(".disable_block").hide();
        $(".timeline-disable").hide();
                 $(".audio-play_1").removeClass("disable-play-icon");
        $(".audio-pause").removeClass("disable-pause-icon");
        $(".replay-audio").removeClass("disable-replay-icon");
        $(".jp-mute").removeClass("disable-mute-icon");
          $(".nextFrame").removeClass("hide");
		  
	});
	</script>
<style type="text/css">
    .popup_frame8{    float: none;
    position: absolute;
    z-index: 80;
    width: 70%;
    background: #f0f0f0;
    margin: 120px auto;
    height: 328px;
    border-radius: 10px;
    border: 2px solid #f4f4f4;
        -webkit-box-shadow: 0px 0px 16px 0px rgba(0,0,0,0.75);
    -moz-box-shadow: 0px 0px 16px 0px rgba(0,0,0,0.75);
    box-shadow: 0px 0px 16px 0px rgba(0,0,0,0.75);
            left: 10em;
}
    .popup_overlay8{    float: none;
    position: relative;
    z-index: 70;
    width: 1024px;
    background-color: rgba(0, 0, 0, 0.6);
    margin: -413px auto;
    height: 531px;
    /* border-radius: 10px; */
    /* border: 2px solid #f4f4f4; */
    opacity: 0.5;
        -webkit-opacity:0.5;

-moz-opacity:0.5;

    right: 24px;}
    .bg{     background: url(images/f8/left-image.png);
    background-repeat: no-repeat;
    height: 557px;
    background-position: 0px 16px;}
    </style>
    </head> 
    <body> 
	  <div class="row bg animated fadeIn">
        <div class="col s12">
            <div class="audio-slides">
                <div data-slide-time="0">
               
                </div>
                <div class="page_box2  animated fadeIn" data-slide-time="0.5">
                 <div class="box-title">Clinical Impact</div>
                   <div class="col s12 learning-objective">
        
                   </div>
              </div>
          <div class="bullet-background-image animated fadeInRight bullet1" data-slide-time="7">Adhesions were reported to be the cause of obstruction in 74% of SBO patients</div>
       <div class="bullet-background-image animated fadeInRight bullet2" data-slide-time="14">Becker et al showed omental adhesions in 79% of the untreated control patients</div>
            <div class="bullet-background-image animated fadeInRight bullet3" data-slide-time="27">Suturing of the peritoneum when closing the abdomen is associated with suboptimal healing</div>
                 <div class="bullet-background-image animated fadeInRight bullet4" data-slide-time="34">Becker study</div>
                   <div class="subbullet-background-image animated fadeInRight bullet5" data-slide-time="41">A portion of the small intestine adhered to the midline incision in 63% of cases</div>

				  
              
  
		</div>
        
        <div class="audio-slides">
            <div class="animated fadeIn popup_frame8" data-slide-time="46"></div>
            <div class="animated fadeInRight poptext" data-slide-time="48">When interacting with Health Care Professionals, you must discuss all three points related to SBO reduction included in the Clinical Studies Section of Seprafilm’s FDA-approved labeling. Specifically, in a post-approval study of Seprafilm<sup>®</sup> of 1791 patients undergoing adhesiolysis for existing SBO:
			          
			</div>
 <!--<div class="popup_overlay8 animated fadeIn" data-slide-time="49"></div>-->
        			<div class="popbullet1 animated fadeInRight bullet-background-image" style="list-style-type:none;" data-slide-time="71">Using protocol defined criteria, 15 of the 840 intestinal resection patients (1.8%) in the Seprafilm<sup>®</sup> group experienced an adhesive SBO that required reoperation compared to 29 of 861 intestinal resection patients (3.4%) in the control group (p < 0.05 ).</div>
				<div class="popbullet1 topmove animated fadeInRight bullet-background-image" style="list-style-type:none;" data-slide-time="93">When all cases of bowel obstruction were considered, including those in which bowel obstruction could not be ruled out, 109 of 888 patients (12%) in the Seprafilm<sup>®</sup> group and 106 of 903 patients (12%) in the control group had bowel obstruction.</div>
				<div class="popbullet1 topmove1 animated fadeInRight bullet-background-image" style="list-style-type:none;" data-slide-time="113">Of the 90 patients with existing bowel obstructions, no significant difference in incidence of adhesive SBO requiring reoperation was found (3 of the 48 Seprafilm<sup>®</sup> patients versus 1 of 42 control patients).</div>  
            
            </div>  
	
			
          
        </div>
        </div>
</body>
</html>


